These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12742856)
21. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Kaushik S; Gupta V; Gupta A; Dogra MR; Singh R Am J Ophthalmol; 2004 Apr; 137(4):758-60. PubMed ID: 15059722 [TBL] [Abstract][Full Text] [Related]
22. Intravitreal triamcinolone acetonide may increase the intraocular pressure even in vitrectomized eyes after more than 3 months. Meyer CH; Mennel S; Schmidt JC Am J Ophthalmol; 2005 Oct; 140(4):766-7; author reply 767-8. PubMed ID: 16226547 [No Abstract] [Full Text] [Related]
23. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Jones R; Rhee DJ Curr Opin Ophthalmol; 2006 Apr; 17(2):163-7. PubMed ID: 16552251 [TBL] [Abstract][Full Text] [Related]
24. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Gillies MC; Simpson JM; Billson FA; Luo W; Penfold P; Chua W; Mitchell P; Zhu M; Hunyor AB Arch Ophthalmol; 2004 Mar; 122(3):336-40. PubMed ID: 15006845 [TBL] [Abstract][Full Text] [Related]
25. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide. Agrawal S; Agrawal J; Agrawal TP Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813 [TBL] [Abstract][Full Text] [Related]
26. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Singh IP; Ahmad SI; Yeh D; Challa P; Herndon LW; Allingham RR; Lee PP Am J Ophthalmol; 2004 Aug; 138(2):286-7. PubMed ID: 15289140 [TBL] [Abstract][Full Text] [Related]
27. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH; Lee CS; Lee SC Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. Dada T; Dhawan M; Garg S; Nair S; Mandal S J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079 [TBL] [Abstract][Full Text] [Related]
31. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases. Jonas JB; Schlichtenbrede F Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions. Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250 [No Abstract] [Full Text] [Related]
33. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion. Ozkiris A; Evereklioglu C; Erkilic K; Dogan H Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039 [TBL] [Abstract][Full Text] [Related]
34. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial. Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423 [TBL] [Abstract][Full Text] [Related]